Brainstorm Cell Therapeutics reported $86K in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Biogen USD 1.85B 234M Sep/2025
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Cipla INR 74.61B 19.39B Sep/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.38M 448K Dec/2025
CSL USD 4.32B 1.35B Dec/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 441.27M 95.24M Dec/2025
Mesoblast USD 43.3M 28.43M Dec/2025